- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03177772
Group Therapy For Dementia Caregivers At Risk For Complicated Grief (PLGT)
Study Overview
Detailed Description
In the investigators previous evaluation of Complicated Grief Group Therapy (CGGT) in bereaved dementia caregivers (2014-NIRG-305569), CGGT was administered to participants in a prospective, randomized-controlled trial. Participants in 5 treatment groups confirmed clinically significant reduction in complicated grief on the Inventory of Complicated Grief. In that study, intervention elements suitable for adaption in a preventative care approach were identified. The investigators are adapting these elements of CGGT for soon-to-be bereaved dementia caregivers at risk for complicated grief-Pre-Loss Group Therapy (PLGT) to facilitate healthy death preparedness and eventual bereavement.
Specific Aims: 1) Assess preparedness for death and grief of bereaved and soon-to-be bereaved caregivers. 2) Adapt CGGT treatment elements into a manualized pre-loss preparedness group psychotherapy-(PLGT)-for dementia caregivers at risk for complicated grief. 3) Implement and evaluate three PLGT cohorts (NTotal = 40) in three long-term care facilities with family caregivers at-risk for complicated grief whose care recipient has a life expectancy of 6 months or less and resides in a long-term care facility.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84115
- St. Joseph Villa
-
Salt Lake City, Utah, United States, 84117
- Silverado Care Facility
-
Salt Lake City, Utah, United States, 84148
- William E. Christoffersen Veterans Home
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Study participants will be ADRD caregivers at risk for CG with a family member diagnosed with ADRD having a life expectancy of less than 6 months and residing in the facility. Caregivers with ADRD residents nearing death will be temporally closer to their grief/preparedness experience permitting 3 month post death follow-up within the study timeline. Eligibility (stage 1). Potential family caregiver participants will be identified by facility leadership (Medical Director, Social Worker and Director of Nursing) by these inclusion criteria:
- resident ADRD diagnosis,
- life expectancy, "Would you be surprised if this resident died in the next 6 months?" and
- caregiver proximity to facility permitting participation. Potential participants will receive an invitation phone call from the ResearchAssistant (RA). Eligibility (stage 2). Interested individuals will be invited to a pre-screening interview with the RA in person at the facility. Those who meet the final inclusion criteria,
- minimum score of 4 on p-BGQ, and
- positive scores on 4 of 9 risk factors will qualify
Exclusion Criteria:
- Active suicidality (likely hospitalization) will exclude interested individuals from participating
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
LTC Facility 1
Pre-loss Grief Support Group offered in long-term care facility for dementia family caregivers anticipating the death of their care recipient within next 6 month.
Two hour sessions for 10 weeks include psychoeducation, motivational interviewing, cognitive behavioral and exposure approaches.
Supportive others, selected by participants are included in two sessions.
|
The PLGT intervention will include CGGT treatment elements modified to address the pre-loss preparation of caregivers at risk for complicated grief, and will focus on the perceived relationship and attachment status between caregiver and care recipient, how memories of the life together, the illness and the death are interpreted, and strategies for preparing for life without the care recipient.
These activities include elements of motivational interviewing, cognitive behavioral therapy and prolonged exposure therapy.
|
LTC Facility 2
Pre-loss Grief Support Group offered in long-term care facility for dementia family caregivers anticipating the death of their care recipient within next 6 month.
Two hour sessions for 10 weeks include psychoeducation, motivational interviewing, cognitive behavioral and exposure approaches.
Supportive others, selected by participants are included in two sessions.
|
The PLGT intervention will include CGGT treatment elements modified to address the pre-loss preparation of caregivers at risk for complicated grief, and will focus on the perceived relationship and attachment status between caregiver and care recipient, how memories of the life together, the illness and the death are interpreted, and strategies for preparing for life without the care recipient.
These activities include elements of motivational interviewing, cognitive behavioral therapy and prolonged exposure therapy.
|
LTC Facility 3
Pre-loss Grief Support Group offered in long-term care facility for dementia family caregivers anticipating the death of their care recipient within next 6 month.
Two hour sessions for 10 weeks include psychoeducation, motivational interviewing, cognitive behavioral and exposure approaches.
Supportive others, selected by participants are included in two sessions.
|
The PLGT intervention will include CGGT treatment elements modified to address the pre-loss preparation of caregivers at risk for complicated grief, and will focus on the perceived relationship and attachment status between caregiver and care recipient, how memories of the life together, the illness and the death are interpreted, and strategies for preparing for life without the care recipient.
These activities include elements of motivational interviewing, cognitive behavioral therapy and prolonged exposure therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Grief
Time Frame: 3 months post death of care recipient
|
Change in pre-loss grief as measured by Inventory of Complicated Grief-revised (Prigerson, et al., 1995; ICG-r)
|
3 months post death of care recipient
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Meaning Making
Time Frame: 3 months post death of care recipient
|
Change in meaning making as measured by Grief and Meaning Reconstruction Inventory, (Gillies, et al., 2015; GMRI)
|
3 months post death of care recipient
|
Preparedness
Time Frame: 3 months post death of care recipient
|
Change in perceived preparedness for death of care recipient as measured by Preparedness question; "How prepared are you/were you for the death of your (spouse/parent)?" (Herbert, Dang & Schulz, 2006).
|
3 months post death of care recipient
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AARG-17-503706
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Data/Documents
-
Study Protocol
Information identifier: dtp38Information comments: Open Science Framework. we are registered
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Grief
-
Universitat Jaume ICompleted
-
Memorial Sloan Kettering Cancer CenterCalvary Hospital, Bronx, NYCompleted
-
Ludwig-Maximilians - University of MunichCompleted
-
University of SaskatchewanSaskatchewan Health Research FoundationCompleted
-
NYU Langone HealthTerminated
-
Ersta Sköndal University CollegeCompleted
-
University of TromsoUnknownComplicated Grief
-
Mayo ClinicRecruiting
-
Universite du Quebec en OutaouaisFonds de la Recherche en Santé du Québec; Canadian Research Chair in Family...Unknown
Clinical Trials on Pre-loss group therapy
-
University of South AlabamaAmerican Society for Metabolic and Bariatric SurgeryCompletedType 2 DiabetesUnited States
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Kaiser PermanenteUniversity of Minnesota; Oregon Research InstituteCompleted
-
Nemours Children's ClinicCompleted
-
Northwestern UniversityCompletedCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Endometrial Cancer | Uterine CancerUnited States
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office...CompletedObesity | Overweight | Weight Loss | Overweight and ObesityUnited States
-
VA Office of Research and DevelopmentCompleted
-
University of North Carolina, Chapel HillCompleted